News Releases

News Releases

  • Jul 17, 2017

    Summary ToggleCo-Diagnostics, Inc. to Use IPO Proceeds to Expand Operations

    Salt Lake City, UT – July 17, 2017 – Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends both to manufacture and sell reagents used for diagnostic tests, has completed its initial public offering and started trading
  • Jul 12, 2017

    Summary ToggleCo-Diagnostics, Inc. Announces Pricing of IPO

    Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests, announced today that its initial public offering of 1,178,532 shares of common stock has been priced at